You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 6,013,285


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,013,285
Title: Large scale production process with instantaneous component mixing and controlled sequential mixing characteristics
Abstract:A method and apparatus for large scale production of a product of in vivo medicine carriers for medicine administration. The reagents are prepared in solution and contained in respective bags. A series pumps and mixing chambers are connected to the reagent bags. The pumps are set at pre-determined rates and activated in a pre-determined sequence within respective pre-determined delay periods, to achieve instantaneous component mixing and controlled sequential mixing characteristics.
Inventor(s): Yen; Richard C. K. (Yorba Linda, CA)
Assignee: Hemosphere, Inc. (Anaheim, CA)
Application Number:08/986,439
Patent Claims:1. A method for large scale production of a product of in vivo medicine carriers, comprising the steps of:

a.

i) a protein unit including a protein bag and a protein pump connected downstream from said protein bag;

ii) an alcohol unit including an alcohol bag and an alcohol pump connected downstream from said alcohol bag;

iii) a stabilizer unit including a stabilizer bag and a stabilizer pump connected downstream from said stabilizer bag;

iv) a first mixing chamber connected downstream from said protein and alcohol pumps;

v) a second mixing chamber connected downstream from said stabilizer pump and said first mixing chamber;

vi) a product collection bag connected to said third mixing chamber; and

vii) connection tubings interconnecting said bags, pumps, mixing chambers and collection bag;

b. preparing respective solutions of a group of reagents including a protein, an alcohol and a stabilizer, and

i) filling said protein bag with a prepared solution of said protein;

ii) filling said alcohol agent bag with a prepared solution of said alcohol; and

iii) filling said stabilizer bag with a prepared solution of said 20 stabilizer;

c. setting respective pump rates of said pumps for mixing pre-determined amounts of said reagents;

d. activating said pumps in sequence for mixing said reagents in a predetermined order within a pre-determined time period to produce said product, including:

a. pumping an albumin protein solution into a first mixing chamber, and subsequently pumping an alcohol solution to said first mixing chamber, to thereby mix therein said solution of said protein with said solution of said alcohol, resulting in a solution containing protein spheres; and

b. pumping said protein spheres to a second mixing chamber; and

c. pumping a solution of a protein cross-linking agent to said second mixing chamber, to thereby mix therein said solution of protein spheres with said solution of said cross-linking agent, resulting in a solution of cross-linked protein spheres useful as in vivo medicine carriers.

2. The method as defined in claim 1 further including the step of adding a solution of medicine for producing a solution of cross-linked protein spheres carrying medicine.

3. The method as defined in claim 2 wherein said medicine is fibrinogen and said solution of medicine is mixed with said solution of protein.

4. The method as defined in claim 2 wherein the medicine is fibrinogen and said solution of medicine is mixed with said solution of protein spheres.

5. The method as defined in claim 2 wherein said medicine is fibrinogen and said solution of medicine is mixed with said solution of cross-linked protein spheres.

6. The method as defined in claim 1 wherein said alcohol is ethanol.

7. The method as defined in claim 1 wherein said protein cross-linking agent is glutaraldehyde.

8. The method of claim 1 wherein the protein cross-linking agent is glutaraldehyde, the alcohol is ethanol, and the albumin is human serum albumin.

9. The method of claim 2 wherein the protein cross-linking agent is glutaraldehyde the alcohol is ethanol, and the albumin is human serum albumin.

Details for Patent 6,013,285

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2015-06-07
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2015-06-07
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2015-06-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.